Background
John Madey was a physics professor at Duke University who had developed and patented sophisticated free electron laser (FEL) equipment — high-powered laboratory devices used for scientific research. Madey operated a FEL lab at Duke for years, but he and the university eventually fell into a serious dispute about the management of the lab. Duke removed Madey as lab director, and Madey resigned and moved to another university. He took his patents with him, but Duke continued using the FEL equipment in its research programs.
Madey sued Duke for patent infringement, claiming the university’s continued use of his patented equipment violated his rights. Duke raised the “experimental use” defense — a narrow common-law doctrine holding that purely philosophical or academic use of an invention, done without any commercial purpose, does not constitute infringement. Duke argued that because it was a nonprofit educational institution conducting research without any profit motive, it qualified for the defense.
The district court agreed with Duke and granted summary judgment in the university’s favor. Madey appealed to the Federal Circuit, which reversed in a decision with major implications for the relationship between patent rights and academic research.
The Court’s Holding
The Federal Circuit rejected Duke’s experimental use defense and held that the university had infringed Madey’s patents. The court applied a strict test: the experimental use defense is available only for activities that are “solely for amusement, to satisfy idle curiosity, or for strictly philosophical inquiry.” Any use that is in furtherance of the legitimate business of the entity — even a nonprofit entity — falls outside this narrow exception.
Duke’s research activities, the court held, clearly served the university’s legitimate business objectives: maintaining its academic reputation, attracting students and faculty, securing research grants, and advancing its educational mission. These are all core functions of a university, and patents serve as an incentive system precisely because they cover valuable research uses. The fact that Duke was not selling the FEL’s output commercially did not place its research use beyond the scope of patent protection.
The court’s reasoning left the experimental use defense functionally available only in extremely narrow circumstances — essentially, hobbyist or purely philosophical use by individuals with no institutional or commercial stake in the outcome. Academic research at a university, even if done without any direct profit motive, was simply too enmeshed with the university’s institutional purposes to qualify.
Key Takeaways
- The experimental use defense to patent infringement is extremely narrow and applies only to uses that are purely philosophical, recreational, or satisfying idle curiosity.
- Universities are not exempt from patent infringement liability simply because they are nonprofit institutions; research serves their legitimate business purposes.
- Any use that advances the user’s business objectives — even broadly defined — falls outside the experimental use defense.
- Academic researchers and institutions must obtain licenses or design-arounds for patented research tools and equipment.
- The decision highlighted a significant gap in U.S. patent law compared to many other countries, which provide broader research exemptions.
Why It Matters
Madey sent shockwaves through the academic research community. Before this decision, many universities operated under the informal assumption that research conducted without profit motive was either not infringement or fell within a broad research exemption. Madey demolished that assumption. The ruling meant that universities needed to take seriously their obligations to license patented research tools — microscopes, reagents, software, lab equipment — that they used in their programs.
The decision also intensified policy debates about the relationship between the patent system and academic science. If universities cannot freely use patented research tools, the cost and complexity of academic research increases, and fundamental science may be hampered. Congress considered but ultimately declined to legislate a broader research exemption after Madey. The case remains a central reference point for any discussion of patent rights in the research environment, and its logic was reinforced by the subsequent Supreme Court decision in Laboratory Corp. v. Metabolite (2006), which raised but avoided the question of whether naturally occurring correlations can be patented.